关注
Nic Fisk
Nic Fisk
其他姓名Nicholas Fisk, Nick Fisk, J Nic Fisk
Assistant Professor, University of Rhode Island
在 uri.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
DNA→ RNA: what do students think the arrow means?
LK Wright, JN Fisk, DL Newman
CBE—Life Sciences Education 13 (2), 338-348, 2014
1022014
Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation
JW Austin, CM Buckner, L Kardava, W Wang, X Zhang, VA Melson, ...
Science translational medicine 11 (520), eaax0904, 2019
812019
Molecular biology and evolution of cancer: from discovery to action
JA Somarelli, H Gardner, VL Cannataro, EF Gunady, AM Boddy, ...
Molecular biology and evolution 37 (2), 320-326, 2020
752020
Development of the central dogma concept inventory (CDCI) assessment tool
DL Newman, CW Snyder, JN Fisk, LK Wright
CBE—Life Sciences Education 15 (2), ar9, 2016
662016
Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders
M Ho, B Thompson, JN Fisk, DW Nebert, EA Bruford, V Vasiliou, ...
Human Genomics 16, 1-21, 2022
562022
PhyInformR: phylogenetic experimental design and phylogenomic data exploration in R
A Dornburg, JN Fisk, J Tamagnan, JP Townsend
BMC Evolutionary Biology 16, 1-7, 2016
402016
p53 binding sites in normal and cancer cells are characterized by distinct chromatin context
F Bao, PR LoVerso, JN Fisk, VB Zhurkin, F Cui
Cell Cycle 16 (21), 2073-2085, 2017
392017
Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma
JN Fisk, AR Mahal, A Dornburg, SG Gaffney, S Aneja, JN Contessa, ...
Cancer letters 526, 346-351, 2022
102022
Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation. 2019
JW Austin, CM Buckner, L Kardava, W Wang, X Zhang, VA Melson, ...
Sci Transl Med 11, 520, 0
5
Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute …
JD Mandell, JN Fisk, E Cyrenne, ML Xu, VL Cannataro, JP Townsend
Leukemia 36 (12), 2931-2933, 2022
42022
Mutation of NOTCH1 is selected within normal esophageal tissues, yet leads to selective epistasis suppressive of further evolution into cancer
KA Glasmacher, VL Cannataro, JD Mandell, M Jackson, JN Fisk, ...
bioRxiv, 2023.11. 03.565535, 2023
12023
Abstract C030: Evolutionary and epistatic analyses reveal genic interactions with KRAS during malignant progression of pancreatic ductal adenocarcinoma
N Fisk, D Song, M Moore, CG Jensen, VL Cannataro, M Nagib, ...
Cancer Research 84 (17_Supplement_2), C030-C030, 2024
2024
Exploiting pronounced selection pressure from therapeutic bottlenecks to identify orthogonal immunotherapy targets
JN Fisk, JP Townsend
Cancer Research 84 (6_Supplement), 548-548, 2024
2024
Persistence and dynamics of mutation, selection, and epistasis during the somatic evolution of low-risk, high-risk, and metastatic prostate cancer
M Rajaei, A Yang, CN Cross, JN Fisk, EB Perry, JD Mandell, SG Gaffney, ...
Cancer Research 84 (6_Supplement), 1627-1627, 2024
2024
Abstract IA010: Unraveling mutation and selection to better understand early cancer evolution
VL Cannataro, KA Glasmacher, M Summers, JD Mandell, JN Fisk, ...
Cancer Research 84 (3_Supplement_2), IA010-IA010, 2024
2024
Abstract A035: Mutation of NOTCH1 is selected within normal esophageal tissues, yet leads to selective epistasis suppressive of further evolution into cancer
KA Glasmacher, VL Cannataro, JD Mandell, M Jackson, JN Fisk, ...
Cancer Research 84 (3_Supplement_2), A035-A035, 2024
2024
Abstract IA006: Leveraging the extreme selection induced by therapeutic bottlenecks to subvert resistance via identifying evolutionarily-informed targets for orthogonal …
JN Fisk, K Politi, S Gettinger, JP Townsend
Cancer Research 84 (3_Supplement_2), IA006-IA006, 2024
2024
Leveraging the extreme selection induced by therapeutic bottlenecks to subvert resistance via identifying evolutionarily-informed targets for orthogonal immunotherapy
J Fisk, K Politi, S Gettinger, JP Townsend
CANCER RESEARCH 84 (3), 2024
2024
Purifying selection and adaptive evolution proximate to the zoonosis of SARS-CoV-1 and SARS-CoV-2
JP Townsend, S Gaughran, HB Hassler, JN Fisk, M Nagib, Y Wu, Y Wang, ...
bioRxiv, 2023.08. 07.552269, 2023
2023
Extreme selection constrains ability of EGFR-driven lung adenocarcinoma to diversify in response to erlotinib therapy
JN Fisk, S Gaffney, K Politi, S Gettinger, F de Miguel, J Townsend
Cancer Research 83 (7_Supplement), 126-126, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20